American Society of Hirudotherapy

Intramuscular Near-Infrared Spectroscopy for Muscle Flap Monitoring in a Porcine Model

Research article published in Journal of reconstructive microsurgery (2021)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Clinical LiteratureBai W et al. · Journal of reconstructive microsurgery, 2022

Abstract

BACKGROUND:  Current near-infrared spectroscopy (NIRS)-based systems for continuous flap monitoring are limited to flaps which carry a cutaneous paddle. As such, this useful and reliable technology has not previously been applicable to muscle-only free flaps where other modalities with substantial limitations continue to be utilized. METHODS:  We present the first NIRS probe which allows continuous monitoring of local tissue oxygen saturation (StO2) directly within the substance of muscle tissue. This probe is flexible, subcentimeter in scale, waterproof, biocompatible, and is fitted with resorbable barbs which facilitate temporary autostabilization followed by easy atraumatic removal. This novel device was compared with a ViOptix T.Ox monitor in a porcine rectus abdominus myocutaneous flap model of arterial and venous occlusions. During these experiments, the T.Ox device was affixed to the skin paddle, while the novel probe was within the muscle component of the same flap. RESULTS:  The intramuscular NIRS device and skin-mounted ViOptix T.Ox devices produced very similar StO2 tracings throughout the vascular clamping events, with obvious and parallel changes occurring upon vascular clamping and release. The normalized cross-correlation at zero lag describing correspondence between the novel intramuscular NIRS and T.Ox devices was >0.99. CONCLUSION:  This novel intramuscular NIRS probe offers continuous monitoring of oxygen saturation within muscle flaps. This experiment demonstrates the potential suitability of this intramuscular NIRS probe for the task of muscle-only free flap monitoring, where NIRS has not previously been applicable. Testing in the clinical environment is necessary to assess durability and reliability.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAnimalsMusclesMyocutaneous FlapOxygenPlastic Surgery ProceduresReproducibility of ResultsSpectroscopy, Near-InfraredSwine

Summary

A flexible subcentimeter intramuscular NIRS probe enabled continuous tissue oxygen saturation monitoring within muscle in a porcine myocutaneous flap model, with tracings closely paralleling a skin-mounted commercial device (cross-correlation >0.99) during vascular clamping.

Context

This study describes a novel intramuscular near-infrared spectroscopy (NIRS) probe for continuous monitoring of tissue oxygen saturation within muscle flaps, tested in a porcine rectus abdominus myocutaneous flap model involving arterial and venous occlusion. The probe demonstrated high cross-correlation with a commercially available skin-mounted NIRS device during vascular clamping events. The abstract makes no mention of leeches, hirudin, hirudotherapy, or any leech-derived products, and the study addresses surgical monitoring technology and flap physiology.

Citation

Reference (Vancouver style)

Bai W, Guo H, Ouyang W, Weng Y, Wu C, Liu Y, et al. Intramuscular Near-Infrared Spectroscopy for Muscle Flap Monitoring in a Porcine Model. J Reconstr Microsurg. 2022;38(4):321-327. doi:10.1055/s-0041-1732361. PMID: 34553344

Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.

Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.